Baker CC, Huynh T. Sepsis in the critically ill patient. Curr Probl Surg 1995; 32: 1015–1083.
Carcillo JA. Pediatric septic shock and multiple organ failure. Crit Care Clin 2003; 19: 413–440.
Bone RC. Sepsis syndrome; new insights into its pathogenesis and treatment. Infect Dis Clin North Am 1991; 5: 793–805.
Wheeler AP, Bernard GR. Treating patients with severe sepsis. New Engl J Med 1999; 340: 207–214.
Hardaway RM. A review of septic shock. Am Surg 2000; 66: 22–29.
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117–123.
Sakorafas GH. Multiple Organ Failure Syndrome (Monograph).Athens, Greece: Diaton Publications, 1990: 1–50.
Hebert PC, Drummond AJ, Singer J, Bernard GR, Russell JA. A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993; 104: 230–235.
Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000; 16: 337–352.
Piper RD, Sibbald WJ. Multiple organ dysfunction syndrome: the relevance of persistent infection and inflammation. In: Fein AM, Abraham ED, Balk RA, et al., eds. Sepsis and Multiorgan Failure.Baltimore, USA:Williams & Wilkins, 1997: 189–208.
Light RB. Septic shock. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care.New York, USA: McGraw-Hill, 1992: 1172–1185.
Field S, Kelly SM, Macklem PT. The oxygen cost of breathing with cardiorespiratory disease. Am Rev Respir Dis 1982; 126: 9–13.
Martin GS, Bernard GR. Airway and lung in sepsis. Intens Care Med 2001; 27: S63–S79.
Tobin MJ. Mechanical ventilation. New Engl J Med 1994; 330: 1056–1061.
Stoller JK. Current controversies in applying specific modes of mechanical ventilation. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care.New York, USA: McGraw-Hill, 1992: 155–159.
Carmichael LC, Dormisky PM, Higgins SB, et al. Diagnosis and therapy of acute respiratory distress syndrome in adults: an international survey. J Crit Care 1996; 11: 9–18.
Hickling KG. Permissive hypercapnia. Respir Care Clin North Am 2002; 8: 155–169.
McHugh LG, Milberg JA, Whitcomb ME, Schoene RB, Maunder RJ, Hudson LD. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150: 90–94.
Hall JB, Wood LDH. Liberation of the patient from mechanical ventilation. JAMA 1987; 257: 1621–1627.
Pulmonary artery catheter consensus conference: consensus statement. Crit Care Med 1997; 25: 910–925.
Connors JrAF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996; 276: 889–897.
Abou-Khalil B, Scalea TM, Trooskin SZ, Henry SM, Hitchcock R. Hemodynamic responses to shock in young trauma patients: need for intensive monitoring. Crit Care Med 1994; 22: 633–639.
Vincent JL. Hemodynamic support in septic shock. Intens Care Med 2001; 27: S80–S92.
Rackow EC, Falk JL, Fein IA, et al. Fluid resuscitation in septic shock. Crit Care Med 1983; 11: 839–850.
Meumann M, Demling RH. Colloid vs. crystalloid: a current perspective. Confed Aust Crit Care Nurses J 1990; 3: 30–35.
Levine R, Alvarez FG. Intravenous fluid therapy. Hosp Physician 1994; 30: 21–37.
Velanovich V. Crystalloid versus colloid fluid resuscitation: meta-analysis of mortality. Surgery 1989; 105: 65–71.
Bunnell E, Parrillo JE. Cardiac dysfunction during septic shock. Clin Chest Med 1996; 17: 237–248.
Walley KR, Wood LDH. Cardiovascular disorders in the critically ill. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care.New York, USA: McGraw-Hill, 1992: 1393–1416.
Mileski WJ. Sepsis. Surg Clin North Am 1991; 71: 749–764.
Hayes MA, Yau EHS, Timmins AC, Hinds CJ, Watson D. Response of the critically ill patients to treatment aimed at achieving supranormal oxygen delivery and consumption. Chest 1993; 103: 886–895.
Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 1990; 112: 492–498.
Boyd O, Grounds M, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993; 270: 2699–2707.
Russell JA, Phang PT. The oxygen delivery/consumption controversy: approaches to management of the critically ill. Am J Respir Crit Care Med 1995; 149: 533–537.
Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. New Engl J Med 1995; 333: 1025–1032.
Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New Engl J Med 1999; 340: 409–417.
Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. New Engl J Med 1994; 330: 1717–1722.
Marik PE, Sibbald WI. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024–3029.
Light RB. Sepsis syndrome. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care.New York, USA: McGraw-Hill, 1992: 645–655.
Wheeler A, Carmichael L, Christman B, et al. Renal function abnormalities in sepsis. Am J Respir Crit Care Med 1995; 151 (Suppl): A317.
Marini JJ, Wright L. General supportive care of the critically ill patient. Semin Respir Crit Care Med 1997; 18: 3–17.
Cook D. Prevention of stress ulcers and ventilator-associated pneumonia. Semin Respir Crit Care Med 1997; 18: 91–95.
Jain M, Schmidt GA. Venous thromboembolism: prevention and prophylaxis. Semin Respir Crit Care Med 1997; 18: 79–90.
Llewelyn M, Cohen J. Diagnosis of infection in sepsis. Intens Care Med 2001; 27: S10–S32.
Butt W. Septic shock. Pediatr Clin North Am 2001; 48: 601–625.
Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344–355.
Simon D, Trenholme G. Antibiotic selection for patients with septic shock. Crit Care Clin 2000; 16: 215–231.
Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM. Bedside prediction of mortality from bacteremic sepsis: a dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153: 684–693.
Stone HH, Bourneuf AA, Stinson LD. Reliability of criteria for predicting persistent or recurrent sepsis. Arch Surg 1985; 120: 17–20.
Gold H, Moellering R. Antimicrobial-drug resistance. New Engl J Med 1996; 335: 1445–1448.
Smith T, Pearson M, Wilcox K, et al. Emergence of vancomycin resistance in Staphylococcal aureus. New Engl J Med 1999; 340: 493–498.
Friedland I, McCracken G. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New Engl J Med 1994; 331: 377–381.
Chen D, McGeer A, de Azavedo J, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. New Engl J Med 1999; 341: 233–238.
Craig WA. Qualitative susceptibility tests versus quantitative MIC tests. Diagn Microbiol Infect Dis 1993; 16: 231–236.
Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 84–92.
Jenkins JK, Carey PD, Byrne K, Sugerman HJ, Fowler III AA. Sepsis-induced lung injury and effects of ibuprofen pretreatment: analysis of early alveolar events via repetitive bronchoalveolar lavage. Am Rev Respir Dis 1991; 143: 155–161.
Stillwell M, Caplan ES. The septic multiple trauma patient. Infect Dis Clin North Am 1989; 3: 155–183.
Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 1996; 154: 617–624.
Bohnen JM, Solomkin JS, Dellinger PE, Bjornson HS, Page CP. Guidelines for clinical care; anti-infection agents for intra-abdominal infection. A surgical infection society policy statement. Arch Surg 1992; 127: 83–89.
Jimenez MF, Marshall JC. Source control in the management of sepsis. Intens Care Med 2001; 27: S49–S62.
Sprung CL, Finch RG, Thijs LG, Glauser MP. International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med 1996; 24: 1441–1447.
Sakorafas GH. Multi-organ failure as an indication for exploratory laparotomy. Arch Hellenic Surg (Gr) 1989; 56: 37–42.
Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiological analysis of seventy-seven cases. Ontario group A streptococcal study. Am J Med 1997; 103: 18–24.
Eriksson B, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infection and the streptococcal toxic shock syndrome. Clin Infect Dis 1998; 27: 1428–1436.
Majeski JA, Alexander JW. Early diagnosis and surgical treatment of necrotizing fasciitis. Surg Gynecol Obstet 1983; 157: 784–807.
Moss RL, Musemeche CA, Kosloske AM. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 1996; 31: 1142–1146.
Adant JP, Bluth F, Fissetter J. Necrotizing fasciitis; a life-threatening infection. Acta Chir Belg 1998; 98: 102–106.
Condon RE. Necrotizing skin and soft tissue infections. In: Rakel R, ed. Conn's Current Therapy.Philadelphia, USA: WB Saunders, 1998: 87–90.
Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality; a retrospective study. Am Surg 1998; 64: 397–400.
Lewis RT. Soft tissue infections. World J Surg 1998; 22: 146–155.
Brown G, Chamberlain R, Goulding J, Clarke A. Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections. J Emerg Med 1996; 14: 547–551.
McHenry CR, Brandt CP, Piotrowski JJ, Jacobs DG, Malagnoni MA. Idiopathic necrotizing fasciitis; recognition, incidence, and outcome of therapy. Am Surg 1994; 60: 490–494.
Davies HD, McGeer A, Schartz B, et al. The Ontario group A streptococcal study group. Invasive group A streptococcal infections in Ontario, Canada. New Engl J Med 1996; 335: 547–554.
Nichols RL. Diagnosis and treatment of uncomplicated and complicated surgical infections. Surgery 2000; 128: S19–S30.
Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol 1995; 154: 89–92.
Bartlet P, Reingold AL, Graham DR, et al. Toxic shock associated with surgical wound infection. JAMA 1982; 247: 1448–1450.
Norrby-Teglud A, Low DE, McGeer A, Kotb M. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients. Adv Exp Med Biol 1997; 418: 563–566.
Fry DE. Toxic shock syndrome. In: Fry DE, ed. Surgical Infection.Boston, USA: Little Brown, 1995: 569–576.
Sirinek KR. Diagnosis and treatment of intra-abdominal abscesses. Surg Infect 2000; 1: 31–38.
Montgomery RS, Wilson SE. Intraabdominal abscesses: image-guided diagnosis and therapy. Clin Infect Dis 1996; 23: 28–36.
Barkhausen J, Stoblen F, Dominguez-Fernandez E, Henseke P, Muller RD. Impact of CT in patients with sepsis of unknown origin. Acta Radiol 1999; 40: 552–555.
Lal NR, Kazerooni EA, Bree RL. Development and implementation of an appropriateness guideline for use of CT in cases of suspected intraabdominal abscess. Acad Radiol 2000; 7: 711–716.
Levison MA. Percutaneous versus open operative drainage of intra-abdominal abscesses. Infect Dis Clin North Am 1992; 6: 525–544.
Khurrum Baig M, Hua Zhao R, Batista O, et al. Percutaneous postoperative intra-abdominal abscess drainage after elective colorectal surgery. Tech Coloproctol 2002; 6: 159–164.
Marano I, Mainenti PP, Selva G, Cannavale M, Sodano A. Computerized tomography-guided drainage of postoperative abdominal fluid collections. Radiol Med 1999; 97: 160–165.
Bufalari A, Giustozzi G, Moggi L. Postoperative intraabdominal abscesses: percutaneous versus surgical treatment. Acta Chir Belg 1996; 96: 197–200.
Thanos L, Dailiana T, Papaioannou G, Nikita A, Koutrouvelis H, Kelekis DA. Percutaneous CT-guided drainage of splenic abscess. Am J Roentgenol 2002; 179: 629–632.
Lankisch PG, Pflichthofer D, Lehnick D. No strict correlation between necrosis and organ failure in severe acute pancreatitis. Pancreas 2000; 20: 319–322.
Bassi C, Falconi M, Girelli F, et al. Microbiological findings in severe pancreatitis. Surg Res Commun 1989; 5: 1–4.
Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999; 86: 1020–1024.
Gloor B, Muller CA, Worni M, Mantignoni ME, Uhl W, Buchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001; 88: 975–979.
Banks PA, Gerzof SG, Langevin RE, Silverman SG, Sica GT, Hughes MD. CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome. Int J Pancreatol 1995; 18: 265–270.
British Society of Gastroenterology: United Kingdom guidelines for the management of acute pancreatitis. Gut 1998; 42 (Suppl 2): S1–S13.
Uhl W, Warshaw A, Imrie C, et al. IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002; 2: 565–573.
Widdison AL, Karanjia ND. Pancreatic infection complicating acute pancreatitis. Br J Surg 1993; 80: 148–154.
Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis. Treatment strategy according to the status of infection. Ann Surg 2000; 232: 619–626.
Fernandez-del Castillo C, Rattner DW, Makary MA, Mostafavi A, McGrath D, Warshaw AL. Debridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 1998; 228: 676–684.
Sarr MG, Nagorney DM, Mucha PJ, Farnell MB, Johnson CD. Acute necrotizing pancreatitis: management by planned, staged pancreatic necrosectomy/debridement and delayed primary wound closure over drains. Br J Surg 1991; 78: 576–581.
Tenner S, Sica G, Hughes M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997; 113: 899–903.
Rau B, Pralle U, Uhl W, Schoenberg MH, Berger HG. Management of sterile necrosis in instances of severe acute pancreatitis. J Am Coll Surg 1995; 181: 279–288.
Hartwing W, Maksan SM, Foitzk T, Schmidt J, Herfarth C, Klar E. Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg 2002; 6: 481–487.
Kivilaakso E, Fraki O, Nikki P, Lempinen M. Resection of the pancreas for acute fulminant pancreatitis. Surg Gynecol Obstet 1981; 152: 493–498.
Mier J, Leon EL, Castillo A, Robledo F, Blanco R. Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997; 173: 71–75.
Baron TH, Thaggard WG, Morgan DE, Stanley RJ. Endoscopic therapy for organized pancreatic necrosis. Gastroenterology 1996; 111: 755–764.
Carter CR, McKay CJ, Imrie CW. Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis; an initial experience. Ann Surg 2000; 232: 175–180.
Tsiotos GG, Luque-de Leon E, Soreide JA, et al. Management of necrotizing pancreatitis by repeated operative necrosectomy using a zipper technique. Am J Surg 1998; 175: 91–98.
Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 2001; 49: 87–93.
von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677–685.
Vandecasteele SJ, Van Wijngaerden E, Van Eldere J, Peetermans WE. New insights in the pathogenesis of foreign body infections with coagulase negative staphylococci. Acta Clin Belg 2000; 55: 148–153.
Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. New Engl J Med 1977; 296: 1305–1309.
Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll-plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35: 641–646.
Cook DJ, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systemic review of the literature. Crit Care Med 1997; 25: 1417–1424.
Maki D, Stolz S, Wheeler S, Mermel LA. Prevention of central venous catheter-related blood-stream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 1997; 127: 257–266.
Clarke DE, Raffin TA. Infectious complications of indwelling long-term central venous catheters. Chest 1990; 97: 966–972.
Murray CK, Beckius ML, McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med 2003; 168: 426–427.
Timsit JF. Scheduled replacement of central venous catheters is not necessary. Infect Cont Hosp Epidemiol 2000; 21: 371–374.
Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998; 158: 151–156.
Gajic O, Urrutia LE, Sewani H, Schroeder DR, Cullinane DC, Peters SG. Acute abdomen in the medical intensive care unit. Crit Care Med 2002; 30: 1187–1190.
Kollef MH, Allen BT. Determinants of outcome for patients in the medical intensive care unit requiring abdominal surgery: a prospective, single-center study. Chest 1994; 106: 1822–1828.
Gregor P, Prodger JD. Mead Johnson Critical Care Symposium for the Practicing Surgeon. Abdominal crisis in the intensive care unit. Can J Surg 1988; 31: 331–332.
Stapakis JC, Thickman D. Diagnosis of pneumoperitoneum: abdominal CT vs. upright chest film. J Comput Assist Tomogr 1992; 16: 713–716.
Jacobs JE, Birnbaum BA. Abdominal computed tomography of intensive care unit patients. Semin Roentgenol 1997; 32: 128–141.
Boland GW, Slater G, Lu DS, Eisenberg P, Lee MJ, Mueller PR. Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. Am J Roentgenol 2000; 174: 973–977.
Walsh RM, Popovich MJ, Hoadley J. Bedside diagnostic laparoscopy and peritoneal lavage in the intensive care unit. Surg Endosc 1998; 12: 1405–1409.
Byrne MF, Suhocki P, Mitchell RM, et al. Percutaneous cholecystostomy in patients with acute cholecystitis: experience of 45 patients at a US referral center. J Am Coll Surg 2003; 197: 206–211.
Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol 2002; 43: 229–236.
Gouma DJ. Management of acute cholangitis. Digest Dis 2003; 21: 25–29.
Gedebou TM, Wong RA, Rappaport WD, Jaffe P, Kahsai D, Hunter GC. Clinical presentation and management of iatrogenic colon perforations. Am J Surg 1996; 172: 454–458.
Jentschura D, Raute M, Winter J, Henkel T, Kraus M, Magegold BC. Complications in endoscopy of the lower gastrointestinal tract. Therapy and prognosis. Surg Endosc 1994; 8: 672–676.
Liolios A, Oropello JM, Benjamin E. Gastrointestinal complications in the intensive care unit. Clin Chest Med 1999; 20: 329–324.
Polk HC, Shields CL. Remote organ failure: a valid sign of occult intraabdominal infection. Surgery 1977; 81: 310–313.
Fry DE, Pearlstein L, Fulton RL, Polk HC. Multiple system organ failure: the role of uncontrolled infection. Arch Surg 1980; 115: 136–140.
Ferraris VA. Exploratory laparotomy for potential abdominal sepsis in patients with multiple organ failure. Arch Surg 1983; 118: 1130–1133.
Bunt TJ. Non-directed relaparotomy for intraabdominal sepsis; a futile procedure. Am Surg 1986; 52: 294–298.
McCrory C, Crowley K. Is repeat laparotomy of value in patients with suspected intraabdmominal sepsis in the intensive care unit? Ir J Med Sci 1997; 166: 89–91.
Grant JP. Nutritional support in critically ill patients. Ann Surg 1994; 220: 610–616.
Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications; the results of a meta-analysis. Ann Surg 1992; 216: 172–183.
Kudsk KA, Stone JM, Carpenter G, Sheldon GF. Enteral and parenteral feeding influences mortality after hemoglobin E. Coli peritonitis in normal rats. J Trauma 1983; 23: 605–609.
Kudsk KA. Gut mucosal nutritional support. Enteral nutrition as primary therapy after multiple system trauma. Gut 1994; 35 (Suppl 1): S52–S54.
Sakorafas GH, Krespis EN. Methods of enteral nutrition. Iatriki 1992; 61: 482–491.
Sakorafas GH. Enteral nutrition in Surgery. Hell Armed Force Med Rev 1992; 26: 129–148.
Cerra FB, Benitez MR, Blackburn GL, et al. Applied nutrition in ICU patients; a consensus statement of the American College of Chest Physicians. Chest 1997; 111: 769–778.
Singh G, Harkema JM, Mayberry AJ, Chaudry IH. Severe depression of gut absorptive capacity in patients following trauma or sepsis. J Trauma 1994; 36: 803–809.
Singh G, Chaudry KI, Chudler LC, Chaudry IH. Sepsis produces early depression of gut absorptive capacity restoration with diltiazem treatment. Am J Physiol 1992; 263: R19–R23.
Long C. Metabolic response to injury and illness. Estimation of energy and protein needs from indirect calorimetry and nitrogen balance. J Parenter Enter Nutr 1979; 3: 452–456.
McCarthy MC. Nutritional support in the critically ill surgical patient. Surg Clin North Am 1991; 71: 831–841.
Kalfarentzos J. Nutritional Support. Athens, Greece: Litsas, 1986: 1–130.
Clevenger FW. Nutritional support in the patient with the systemic inflammatory response syndrome. Am J Surg 1993; 165 (Suppl 2A): 68S–74S.
Koretz RL. Nutritional supplementation in the ICU: how critical is nutrition for the critically ill? Am J Respir Crit Care Med 1995; 151: 570–573.
Glauser MP. Pathophysiologic basis of sepsis; considerations for future strategies of intervention. Crit Care Med 2000; 28 (Suppl): S4–S8.
Neugebauer E, Rixen D, Raum M, Schafer U. Thirty years of anti-mediator treatment in sepsis and septic shock: What have we learned? Langenbecks Arch Surg 1998; 383: 26–34.
Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25: 1095–1100.
Kox WJ, Volk T, Kox SN, Volk HD. Immunomodulatory therapies in sepsis. Intens Care Med 2000; 26: S124–S128.
Abraham E, Anzueto A, Cutierrez G, et al. Double-blind randomised controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock. Lancet 1998; 351: 929–933.
Bone RC, Balk RA, Fein AM, et al. A second large controlled study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomised, controlled trial. Crit Care Med 1995; 23: 994–1006.
Angus DC, Birmingham D, Balk RA, et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA 2000; 283: 1723–1730.
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. New Engl J Med 2003; 348: 138–150.
Czermak BJ, Sarma V, Pierson CL, et al. Protective effects of C5a blockade in sepsis. Nat Med 1999; 5: 788–792.
Guo RF, Huber-Lang M, Wang X, et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest 2000; 106: 1271–1280.
Huber-Lang MS, Sarma JV, McGuire SR, et al. Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J 2001; 15: 568–570.
Rogiers P. Hemofiltration treatment for sepsis; is it time for controlled trials? Kidney Int 1999; 56 (Suppl 72): S99–S103.
Gotloid L, Shostak A, Lev A, Fudin R, Jaichenko J. Treatment of surgical and non-surgical septic multiorgan failure with bicarbonate hemodialysis and sequential hemofiltration. Intens Care Med 1995; 21: 104–111.
Bellomo R, Balwin I, Cole Ronco C. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int 1998; 54 (Suppl 66): S182–S185.
Boulain T, Delpech M, Legras A, et al. Continuous venovenous hemofiltration in acute renal failure associated with multiple organ failure: influence on outcome. Clin Intens Care 1996; 7: 4–10.
Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. New Engl J Med 2002; 346: 305–310.
Kollef MH. Opinion: the clinical use of selective digestive decontamination. Crit Care 2000; 4: 327–332.
Bonten MJ, Kullberg BJ, van Dalen R, et al. Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother 2000; 46: 351–362.
Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock. New Engl J Med 1984; 311: 1137–1143.
Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis; a critical reappraisal and meta-analysis of the literature. Crit Care Med 1995; 23: 1430–1439.
Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862–871.
Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock; a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27: 723–732.
Boellaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with suprephysiologic doses of hydrocortisone. Crit Care Med 1998; 26: 645–650.
Spijkstra JJ, Girbes ARJ. The continuing story of corticosteroids in the treatment of septic shock. Intens Care Med 2000; 26: 496–500.
Annane D. Corticosteroids for septic shock. Crit Care Med 2001; 29 (Suppl): S117–S120.
Zaloga GP. Sepsis-induced adrenal deficiency syndrome. Crit Care Med 2001; 29: 688–690.
Shenker Y, Skatrud JB. Adrenal insufficiency in critically ill patients. Am J Respir Crit Care Med 2001; 163: 1520–1523.
Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 2000; 283: 1038–1045.
Abraham E, Evans T. Corticosteroids and septic shock. JAMA 2002; 288: 886–887.
Arons MM, Wheeler AP, Bernard GR, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 1999; 27: 699–707.
Bernard GR, Wheeler AP, Russell JA, et al. Effects of ibuprofen on the physiology and survival of patients with sepsis. New Engl J Med 1997; 336: 912–918.
Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. New Engl J Med 2001; 344: 699–709.
Matthay MA. Severe sepsis – a new treatment with both anticoagulant and anti-inflammatory properties. New Engl J Med 2001; 344: 759–762.
Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile on antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001; 276: 11199–11203.
Cohen J, Guyatt G, Bernard GR, et al. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001; 29: 880–886.
Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration on the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997; 277: 1058–1063.
Warren HS, Suffredini AF, Eichacker PQ, Munford RS. Risks and benefits of activated protein C treatment for severe sepsis. New Engl J Med 2002; 347: 1027–1030.
Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. An economic evaluation of activated protein C for severe sepsis. New Engl J Med 2002; 347: 993–1000.
Siegel JP. Assessing the use of activated protein C in the treatment of severe sepsis. New Engl J Med 2002; 347: 1030–1034.
Levi M, Jonge E, Poll T. Rational for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 2001; 29 (Suppl 7): S90–S94.
Baudo F, Caimi TM, de Cataldo F, et al. Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomised, multicenter study. Intens Care Med 1998; 24: 336–342.
Eisele B, Lamy M, Thijs LG, et al. Antithrombin III in patients with severe sepsis: a randomised, placebo-controlled, double-blind multicenter trial plusa meta-analysis on all randomised, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intens Care Med 1998; 24: 663–672.
Bregengard C, Nordfang O, Wildoose P, Svendsen O, Hedner U, Diness V. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Blood Coagul Fibrin 1993; 4: 699–706.
Elsayed YA, Nakagawa K, Kamikubo YI, Enjyoji KI, Kato H, Sueishi K. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model. Am J Clin Pathol 1996; 106: 574–583.
Inthorn D, Hoffman JN, Hartl WH, et al. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock 1997; 8: 328–334.
Van de Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New Engl J Med 2001; 345: 1359–1367.
Go F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia–reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002; 105: 1497–1502.
Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001; 163: 195–200.
Baudouin S. Sepsis therapies: options for the future: endothelial cell replacement.Program and Abstracts of the 23rd International Symposium on Intensive Care and Emergency Medicine;March 18–21, 2003, Brussels, Belgium.
Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic intervention. FASEB J 2001; 15: 879–892.
Oberholzer C, Oberholzer A, Bahjat FR, et al. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci USA 2001; 98: 11503–11508.
Hotchkiss RS, Tinsley KW, Swanson PE, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999; 96: 14541–14546.
Hotchkiss RS, Chang KC, Swanson PE, et al. Caspace inhibitors improve survival in sepsis; a critical role of the lymphocyte. Nat Immunol 2000; 1: 496–501.
Coopersmith C, Stromberg PR, Dunne WM, et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287: 1716–1721.
Anel RL, Kumar A. Experimental and emerging therapies for sepsis and septic shock. Expert Opin Investig Drugs 2001; 10: 1471–1485.
Herndon DN, Ramzy PI, DebRoy MA, et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 1999; 229: 713–719.
Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995; 222: 283–294.
Ziegler TR, Gatzen C, Wilmore DW. Strategies for attenuating protein-catabolic responses in the critically ill. Ann Rev Med 1994; 45: 459–464.
Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001; 131 (Suppl 9): S2543–S2551.
Zaloga GB, Roberts P. Permissive underfeeding. New Horiz 1994; 2: 257–263.
Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ lymphocytes in humans. J Immunol 2001; 166: 6952–6963.
Zeni F, Freeman BF, Natanson C. Antiinflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25: 1095–1100.
Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes; understanding the role of innate and acquired immunity. Shock 2001; 16: 83–96.
Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3: 678–681.
O'Suilleabhain C, O'Sullivan ST, Kelly JL, Ledered J, Mannick JA, Rodrick ML. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 1996; 120: 290–296.
Caladra T, Echtenacher B, Roy DL, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164–170.
Werdan K. Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. Ther Apher 2001; 5: 115–122.
Werdan K. Supplemental immune globulins in sepsis. Clin Chem Lab Med 1999; 37: 341–349.
Pilz G, Fateh-Moghadam S, Viell B, et al. Supplemental immunoglobulin therapy in sepsis and septic shock. Theor Surg 1993; 8: 61–83.
Pilz G, Fraunberger P, Appel R, et al. Early prediction of outcome in score-identified, postcardiac patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. Crit Care Med 1996; 24: 596–600.
Pilz G, Appel R, Kreuzer E, Werdan K. Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified post-cardiac surgical patients at high-risk for sepsis. Chest 1997; 111: 419–426.